February 16, 2010 (FinancialWire) — Martek Biosciences Corp. (NASDAQ: MATK) said it has completed the purchase of Amerifit Brands, Inc. from Charterhouse Group, Inc. in an all-cash transaction valued at around $200 million.

The acquisition was first reported on January 21.

Amerifit Brands develops, markets and distributes branded consumer health and wellness products focused on women’s and digestive health benefits. Amerifit’s products are sold in most major mass, club, drug, grocery and specialty stores. The company’s main products include Culturelle, a probiotic supplement; AZOÂ, an OTC brand addressing symptom relief, detection and prevention of urinary tract infections; and Estrovena, a nutritional supplement brand addressing the symptoms of menopause.

Maryland-based Martek Biosciences develops omega-3 DHA products, and produces a vegetarian source of the omega-3 fatty acid DHA for use in foods, infant formula and supplements.

It also makes an omega-6 fatty acid for use in infant formula.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.